Delivery Order SPE2DB22D1106-SPE2DB25FFGR1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,068.76 to AmerisourceBergen Drug Corp for Advair HFA 45-21 microgram inhalers (12 grams) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $9,867 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 grams) on August 25, 2025, with completion targeted for August 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $13,747.80 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $10,402.76 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Advair HFA 115-21 microgram inhaler 12-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,648.38 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 grams) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a routine pharmaceutical supply delivery to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $1,900.89 delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhaler (12 grams) under a firm fixed price contract type. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of July 23, 2025, one day after the award date of July 22, 2025. Performance will take place at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued against...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.34 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on August 1, 2025, with a completion date of August 4, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGR1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,766.80 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction within the company's broader pharmaceutical supply portfolio for federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a child contract of this comprehensive global pharmaceutical support vehicle, this order exemplifies the prime contractor's role as a critical vendor supplying medications and medical supplies to military healthcare systems and other federal agencies. AmerisourceBergen's position as a major pharmaceutical distributor enables it to fulfill diverse federal medical procurement requirements across multiple therapeutic domains through competitive delivery orders issued against its large master contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/3/25 |